AiViva Biopharma Appoints Jung-Chin (Rongjin) Lin, to the Board of Directors forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
COSTA MESA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Mr. Jung-Chin (Rongjin) Lin to its board of directors. He is Honorary President of Center Laboratories, Inc. and Chairman of the Board of Lumosa Therapeutics Co., Ltd. and Glac Biotech Co., Ltd. He also serves as a Board member at Adimmune Corp. and BioGend Therapeutics Co., Ltd
Taipei, Nov. 12 (CNA) The latest move by global index provider MSCI Inc. to cut Taiwan's weighting in its major index is expected to have only a minor adverse impact on the local equity market, according to the Financial Supervisory Commission (FSC).
Data reported at the 2022 Annual Meeting of the American Society for Clinical OncologyNBTXR3 is being developed as a product candidate with potential to integrate across the standards of care in oncology, and these data from collaborator-sponsored phase 1b/2 studies add support for the radioenhancer in combination w.
Data reported at the 2022 Annual Meeting of the American Society for Clinical Oncology NBTXR3 is being developed as a product candidate with potential to integrate across the standards of care